Aprea Therapeutics Inc (APRE)
5.40
-0.21
(-3.74%)
USD |
NASDAQ |
Apr 19, 15:08
Aprea Therapeutics Market Cap: 29.32M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 30.46M |
| April 17, 2024 | 31.12M |
| April 16, 2024 | 31.77M |
| April 15, 2024 | 32.04M |
| April 12, 2024 | 31.01M |
| April 11, 2024 | 32.04M |
| April 10, 2024 | 33.67M |
| April 09, 2024 | 32.80M |
| April 08, 2024 | 33.67M |
| April 05, 2024 | 34.21M |
| April 04, 2024 | 33.50M |
| April 03, 2024 | 36.22M |
| April 02, 2024 | 35.84M |
| April 01, 2024 | 34.48M |
| March 28, 2024 | 36.33M |
| March 27, 2024 | 32.96M |
| March 26, 2024 | 32.15M |
| March 25, 2024 | 22.73M |
| March 22, 2024 | 22.87M |
| March 21, 2024 | 23.73M |
| March 20, 2024 | 24.29M |
| March 19, 2024 | 25.19M |
| March 18, 2024 | 24.48M |
| March 15, 2024 | 23.13M |
| March 14, 2024 | 19.84M |
| Date | Value |
|---|---|
| March 13, 2024 | 20.74M |
| March 12, 2024 | 23.02M |
| March 11, 2024 | 25.30M |
| March 08, 2024 | 26.64M |
| March 07, 2024 | 27.84M |
| March 06, 2024 | 30.98M |
| March 05, 2024 | 30.53M |
| March 04, 2024 | 31.39M |
| March 01, 2024 | 29.89M |
| February 29, 2024 | 31.61M |
| February 28, 2024 | 26.90M |
| February 27, 2024 | 27.17M |
| February 26, 2024 | 26.72M |
| February 23, 2024 | 27.05M |
| February 22, 2024 | 23.82M |
| February 21, 2024 | 23.47M |
| February 20, 2024 | 23.47M |
| February 16, 2024 | 21.78M |
| February 15, 2024 | 21.30M |
| February 14, 2024 | 22.31M |
| February 13, 2024 | 22.08M |
| February 12, 2024 | 23.91M |
| February 09, 2024 | 22.42M |
| February 08, 2024 | 25.71M |
| February 07, 2024 | 24.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.77M
Minimum
Jul 10 2023
1.040B
Maximum
Dec 27 2019
206.74M
Average
60.99M
Median
Jan 07 2022
Market Cap Benchmarks
| NeuBase Therapeutics Inc | 1.529M |
| Stoke Therapeutics Inc | 555.64M |
| Processa Pharmaceuticals Inc | 4.570M |
| NovaBay Pharmaceuticals Inc | 2.438M |
| Palatin Technologies Inc | 30.18M |
Market Cap Related Metrics
| Price to Book Value | 1.730 |
| Price | 5.40 |
| Earnings Yield | -73.89% |